Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$14.29 M
• Last year FTD volume: A$14.29 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
MannKind Corp MNKD	A$0.65 M	A$13.58 M	🇺🇸 USA
Eli Lilly LLY	A$41.73 M	A$0.14 B	🇺🇸 USA
Baxter BAX	A$11.62 M	A$53.13 M	🇺🇸 USA
Pfizer PFE	A$50.21 M	A$0.38 B	🇺🇸 USA
Sanofi SNY	A$11.64 M	A$71.88 M	🇫🇷 France
Johnson & Johnson JNJ	A$70.18 M	A$0.32 B	🇺🇸 USA